1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2527)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)

More Groups

People
  1. Marc Ladanyi (1327)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (120)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (263)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (758)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5914)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mutation profile of drug resistant gastrointestinal stromal tumor (GIST) patients (pts) enrolled in the phase 1 study of DCC-2618
    Meeting Abstract

    George, S.; Heinrich, M. C.; Razak, A. R. A.; Chi, P.; Gordon, M. S.; Ganjoo, K. N.; von Mehren, M.; Somaiah, N.; Trent, J. C.; Su, Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genomic landscape, clinical characteristics and outcomes of early onset (EO) compared with average onset (AO) colorectal cancer (CRC)
    Meeting Abstract

    Dos Santos Fernandes, G.; Chatila, W. K.; Yaeger, R.; Mendelsohn, R. B.; Stadler, Z. K.; Segal, N. H.; Varghese, A. M.; Lagunes, D. R.; Diaz, L. A.; Shia, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Pharmacokinetics/pharmacodynamics (PK/PD) of ivosidenib in patients with IDH1-mutant advanced solid tumors from a phase 1 study
    Meeting Abstract

    Fan, B.; Mellinghoff, I. K.; Wen, P. Y.; Pandya, S. S.; Jiang, L.; Liu, G.; Nimkar, T.; Yang, H.; Dai, D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Identification of clonal hematopoiesis mutations in solid tumor patients undergoing unpaired commercial next-generation sequencing assays
    Meeting Abstract

    Coombs, C. C.; Gillis, N.; Bolton, K. L.; Berg, J. S.; Tan, X.; Hayward, M. C.; Patel, N. M.; Ball, M.; Balasis, M.; Mesa, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • DNA damage repair (DDR) germline mutations in patients (Pts) with urothelial carcinoma (UC)
    Meeting Abstract

    Carlo, M. I.; Vijai, J.; Mandelker, D.; Kemel, Y.; Regazzi, A. M.; Zhang, L.; Stadler, Z. K.; Walsh, M. F.; Cadoo, K. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prevalence of germline genetic alterations in colorectal cancer patients
    Meeting Abstract

    Cercek, A.; Kemel, Y.; Mandelker, D.; Stewart, C.; Arnold, A. G.; Sheehan, M.; Yaeger, R.; Segal, N. H.; Varghese, A. M.; Saltz, L. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Alterations in key clear cell renal cell carcinoma (RCC) genes to refine patient prognosis
    Meeting Abstract

    BosseĢ, D.; Xie, W.; Ged, Y.; Hahn, A. W.; Bergerot, P. G.; Ho, T. H.; McKay, R. R.; Rose, T. L.; de Velasco, G.; Tannir, N. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Comprehensive detection of targetable fusions in lung adenocarcinomas by complementary targeted DNAseq and RNAseq assays
    Meeting Abstract

    Benayed, R.; Offin, M. D.; Mullaney, K. A.; Sukhadia, P.; Rios, K. M.; Desmeules, P.; Chang, J. C.; Hyman, D. M.; Berger, M. F.; Zehir, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Microsatellite instability in prostate cancer and response to immune checkpoint blockade
    Meeting Abstract

    Abida, W.; Cheng, M. L.; Armenia, J.; Middha, S.; Autio, K. A.; Rathkopf, D. E.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; Carbone, E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1 study of AG-881, an inhibitor of mutant IDH1/IDH2, in patients with advanced IDH-mutant solid tumors, including glioma
    Meeting Abstract

    Mellinghoff, I. K.; Penas-Prado, M.; Peters, K. B.; Cloughesy, T. F.; Burris, H. A.; Maher, E. A.; Janku, F.; Cote, G. M.; De La Fuente, M. I.; Clarke, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save